CD44-targeted PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer
Cancer Research - United States
doi 10.1158/0008-5472.can-17-3871
Full Text
Open PDFAbstract
Available in full text
Date
August 16, 2018
Authors
Publisher
American Association for Cancer Research (AACR)